1. Home
  2. COGT vs FSUN Comparison

COGT vs FSUN Comparison

Compare COGT & FSUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COGT
  • FSUN
  • Stock Information
  • Founded
  • COGT 2014
  • FSUN 1892
  • Country
  • COGT United States
  • FSUN United States
  • Employees
  • COGT N/A
  • FSUN N/A
  • Industry
  • COGT Biotechnology: Pharmaceutical Preparations
  • FSUN Major Banks
  • Sector
  • COGT Health Care
  • FSUN Finance
  • Exchange
  • COGT Nasdaq
  • FSUN Nasdaq
  • Market Cap
  • COGT 1.0B
  • FSUN 1.1B
  • IPO Year
  • COGT 2018
  • FSUN N/A
  • Fundamental
  • Price
  • COGT $8.00
  • FSUN $41.33
  • Analyst Decision
  • COGT Buy
  • FSUN Buy
  • Analyst Count
  • COGT 6
  • FSUN 3
  • Target Price
  • COGT $14.17
  • FSUN $49.00
  • AVG Volume (30 Days)
  • COGT 1.3M
  • FSUN 69.9K
  • Earning Date
  • COGT 03-04-2025
  • FSUN 01-27-2025
  • Dividend Yield
  • COGT N/A
  • FSUN N/A
  • EPS Growth
  • COGT N/A
  • FSUN N/A
  • EPS
  • COGT N/A
  • FSUN 2.69
  • Revenue
  • COGT N/A
  • FSUN $359,152,000.00
  • Revenue This Year
  • COGT N/A
  • FSUN N/A
  • Revenue Next Year
  • COGT N/A
  • FSUN $7.28
  • P/E Ratio
  • COGT N/A
  • FSUN $15.43
  • Revenue Growth
  • COGT N/A
  • FSUN 1.38
  • 52 Week Low
  • COGT $5.73
  • FSUN $33.31
  • 52 Week High
  • COGT $12.61
  • FSUN $45.32
  • Technical
  • Relative Strength Index (RSI)
  • COGT 41.50
  • FSUN 49.25
  • Support Level
  • COGT $7.88
  • FSUN $38.25
  • Resistance Level
  • COGT $8.37
  • FSUN $44.98
  • Average True Range (ATR)
  • COGT 0.42
  • FSUN 1.98
  • MACD
  • COGT -0.11
  • FSUN -0.18
  • Stochastic Oscillator
  • COGT 5.85
  • FSUN 43.56

About COGT Cogent Biosciences Inc.

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.

About FSUN FirstSun Capital Bancorp

Firstsun Capital Bancorp is the financial holding company for Sunflower Bank, National Association. It provides a full range of deposit, lending, treasury management, wealth management and online banking products and services. The company operates in two segments - Banking operations and Mortgage operations, out of which the majority of the revenue is generated from the Banking operations segment.

Share on Social Networks: